An international expert panel has developed the first consensus-based framework for reporting ‘set and setting’ variables in ...

Psyence Biomedical Ltd. (NASDAQ: PBM) ("Psyence BioMed" or the "Company") today announced that it has received formal notification from the Nasdaq ...

Psyence Biomedical Ltd. (NASDAQ: PBM) ("Psyence BioMed" or the "Company") today announced that it has received formal ...

Expanded platform improves access, scales operations, and advances Incannex’s position in next-generation mental health treatmentNEW YORK and MELBOURNE, Australia, June 17, 2025 (GLOBE NEWSWIRE) -- ...

Magic mushrooms might be key to quelling depression among people battling cancer. A single dose of psilocybin provided ...

Some 7,000 people are expected to attend this week's Psychedelic Science conference in Denver and public health activists are ...

Early results from a pilot study indicate that psilocybin-assisted therapy could be linked to lower alcohol consumption and ...

Texas Governor Greg Abbott signed Senate Bill 2308, promoting ibogaine research for treating opioid addiction, depression, ...

The state’s governor signed legislation to allow clinical trials of a psychedelic drug that shows promise for veterans in ...

All OPTIMIZE study participants receive psilocybin, which has been proven to positively impact patients with depression.